The pathophysiology of noise-induced hearing loss (NIHL) encompasses excessive inflammation, tissue damage, production of reactive oxygen species, and apoptotic processes, culminating in irreversible damage to hair cells. Currently, no clinical interventions are available to mitigate this condition....
No actionable change for clinical practice — findings are limited to a mouse model of noise-induced hearing loss and require human trials before any clinical application can be considered.
Identifying Alpha1-Antitrypsin as a protective agent against noise-induced hearing loss adds to the growing body of evidence that anti-inflammatory and anti-oxidative strategies may be viable targets for otoprotective therapies.
- 01Human Alpha1-Antitrypsin (A1AT) reduced noise-induced hearing loss in a mouse model.
- 02Protective mechanisms included reduced inflammation, reactive oxygen species (cell-damaging molecules), and apoptosis (programmed cell death).
- 03Study is animal (murine) only — no human data; translation to clinical use is speculative at this stage.
- 04Published in OTO Open (Frontiers in Otolaryngology); peer-reviewed.
- 05Adds to research interest in anti-inflammatory and antioxidant approaches for hearing protection.
Human Alpha1-Antitrypsin demonstrated protective effects against noise-induced hearing loss in a mouse model.
studysupportedAlpha1-Antitrypsin reduces reactive oxygen species, inflammation, and apoptosis in noise-exposed murine cochlear tissue.
studysupported- PMID
- 42080005
- DOI
- 10.1002/oto2.70238.
- Journal
- OTO Open
- Publication type
- research_article
- Evidence level
- 4
- Population
- Murine (mouse) model of noise-induced hearing loss
- Intervention
- Administration of human Alpha1-Antitrypsin following noise exposure
- Comparator
- Noise-exposed control mice not receiving Alpha1-Antitrypsin
Primary outcomes
Degree of auditory impairment following noise exposure; Cochlear inflammation and reactive oxygen species levels; Apoptosis and tissue damage markers in cochlear tissue